Ligand validation:7P17

NKP: (2R)-2-hydroxy-3-(phosphonooxy)propyl (9E)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7P17_NKP_M_401	36%	77%	0.188	0.882	0.35	0.57	-	-	0	0	100%	1
7P17_NKP_M_403	23%	74%	0.211	0.836	0.54	0.47	-	-	0	0	100%	1
7P0Q_NKP_M_401	47%	74%	0.172	0.912	0.38	0.61	-	1	0	0	100%	1
7P2C_NKP_M_403	18%	75%	0.236	0.822	0.53	0.46	-	-	0	0	100%	1
8C88_NKP_M_401	12%	85%	0.299	0.825	0.35	0.4	-	-	0	0	100%	1
5DLW_NKP_A_904	60%	81%	0.143	0.93	0.37	0.45	-	-	5	0	100%	1
3NKP_NKP_A_1006	47%	39%	0.187	0.928	0.7	1.67	1	12	7	0	100%	1
8C3P_NKP_B_903	43%	53%	0.21	0.936	0.88	0.95	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.